Jing Wang
Jing Wang
Professor of Bioinformatics, University of Texas M.D.Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Comprehensive genomic characterization of head and neck squamous cell carcinomas
TCGA Network
Nature, 2015
19622015
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ...
Science 333 (6046), 1154-1157, 2011
16752011
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
14742018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
10972018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
9982018
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
9262017
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
8802018
An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
7382013
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
Wei SC, Levine JH, Cogdill AP, Zhao Y, Anang NAS, Andrews MC, Sharma P, Wang ...
Cell, 2017
6472017
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Nat Commun, 2014
613*2014
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Skoulidis F, et al
Cancer Discov, 2018
5562018
Integrated genomic and molecular characterization of cervical cancer.
CGAR Network
Nature, 2017
5412017
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers
CR Pickering, J Zhang, SY Yoo, L Bengtsson, S Moorthy, DM Neskey, ...
Cancer discovery 3 (7), 770-781, 2013
4512013
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, Izzo, ...
Cancer Discovery 5, 860-77, 2015
4482015
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
4352018
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
NT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee, GR Blumenschein, A Tsao, ...
Journal of the National Cancer Institute 104 (3), 228-239, 2012
4002012
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
CGAR Network
Cell, 2017
3942017
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
LA Byers, J Wang, MB Nilsson, J Fujimoto, P Saintigny, J Yordy, U Giri, ...
Cancer Discovery, 2012
3672012
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
3602018
An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
L Seguin, S Kato, A Franovic, MF Camargo, J Lesperance, KC Elliott, ...
Nature cell biology 16 (5), 457-468, 2014
2952014
The system can't perform the operation now. Try again later.
Articles 1–20